Author:
Hoppe B S, ,Moskowitz C H,Zhang Z,Maragulia J C,Rice R D,Reiner A S,Hamlin P A,Zelenetz A D,Yahalom J
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Reference32 articles.
1. Barrington SF, Carr R . Staging of Burkitt's lymphoma and response to treatment monitored by PET scanning. Clin Oncol (R Coll Radiol) 1995; 7: 334–335.
2. Freudenberg LS, Antoch G, Schutt P, Beyer T, Jentzen W, Muller SP et al. FDG-PET/CT in re-staging of patients with lymphoma. Eur J Nucl Med Mol Imaging 2004; 31: 325–329.
3. Moog F, Bangerter M, Diederichs CG, Guhlmann A, Kotzerke J, Merkle E et al. Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging. Radiology 1997; 203: 795–800.
4. Schaefer NG, Hany TF, Taverna C, Seifert B, Stumpe KD, von Schulthess GK et al. Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging—do we need contrast-enhanced CT? Radiology 2004; 232: 823–829.
5. Schoder H, Meta J, Yap C, Ariannejad M, Rao J, Phelps ME et al. Effect of whole-body (18)F-FDG PET imaging on clinical staging and management of patients with malignant lymphoma. J Nucl Med 2001; 42: 1139–1143.
Cited by
54 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献